217 related articles for article (PubMed ID: 26979865)
1. Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice.
Kuroki T; Tanaka R; Shimada Y; Yamashiro K; Ueno Y; Shimura H; Urabe T; Hattori N
Stroke; 2016 May; 47(5):1328-35. PubMed ID: 26979865
[TBL] [Abstract][Full Text] [Related]
2. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.
Chen F; Wang W; Ding H; Yang Q; Dong Q; Cui M
J Neuroinflammation; 2016 Aug; 13(1):204. PubMed ID: 27566245
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats.
Briyal S; Gulati K; Gulati A
Brain Res; 2012 Jan; 1427():23-34. PubMed ID: 22055454
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
Jin R; Xiao AY; Chen R; Granger DN; Li G
Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
[TBL] [Abstract][Full Text] [Related]
5. Exacerbation of Thromboinflammation by Hyperglycemia Precipitates Cerebral Infarct Growth and Hemorrhagic Transformation.
Desilles JP; Syvannarath V; Ollivier V; Journé C; Delbosc S; Ducroux C; Boisseau W; Louedec L; Di Meglio L; Loyau S; Jandrot-Perrus M; Potier L; Michel JB; Mazighi M; Ho-Tin-Noé B
Stroke; 2017 Jul; 48(7):1932-1940. PubMed ID: 28526762
[TBL] [Abstract][Full Text] [Related]
6. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
Kamada H; Yu F; Nito C; Chan PH
Stroke; 2007 Mar; 38(3):1044-9. PubMed ID: 17272778
[TBL] [Abstract][Full Text] [Related]
7. Suppression of hypoxia-inducible factor-1alpha and its downstream genes reduces acute hyperglycemia-enhanced hemorrhagic transformation in a rat model of cerebral ischemia.
Chen C; Ostrowski RP; Zhou C; Tang J; Zhang JH
J Neurosci Res; 2010 Jul; 88(9):2046-55. PubMed ID: 20155812
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Benefits of Adropin in Aged Mice After Transient Ischemic Stroke via Reduction of Blood-Brain Barrier Damage.
Yang C; Liu L; Lavayen BP; Larochelle J; Gunraj RE; Butler AA; Candelario-Jalil E
Stroke; 2023 Jan; 54(1):234-244. PubMed ID: 36305313
[TBL] [Abstract][Full Text] [Related]
9. Hyperbaric Oxygen Reduces Infarction Volume and Hemorrhagic Transformation Through ATP/NAD
Hu Q; Manaenko A; Bian H; Guo Z; Huang JL; Guo ZN; Yang P; Tang J; Zhang JH
Stroke; 2017 Jun; 48(6):1655-1664. PubMed ID: 28495827
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
11. The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.
Li PC; Liu LF; Jou MJ; Wang HK
BMC Neurosci; 2016 Jun; 17(1):37. PubMed ID: 27296974
[TBL] [Abstract][Full Text] [Related]
12. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
13. Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia.
Qin Z; Karabiyikoglu M; Hua Y; Silbergleit R; He Y; Keep RF; Xi G
Stroke; 2007 Apr; 38(4):1362-7. PubMed ID: 17322079
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia.
Teramoto S; Miyamoto N; Yatomi K; Tanaka Y; Oishi H; Arai H; Hattori N; Urabe T
J Cereb Blood Flow Metab; 2011 Aug; 31(8):1696-705. PubMed ID: 21487412
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.
Yang Y; Salayandia VM; Thompson JF; Yang LY; Estrada EY; Yang Y
J Neuroinflammation; 2015 Feb; 12():26. PubMed ID: 25889169
[TBL] [Abstract][Full Text] [Related]
16. Acute hyperglycemia worsens ischemic stroke-induced brain damage via high mobility group box-1 in rats.
Huang J; Liu B; Yang C; Chen H; Eunice D; Yuan Z
Brain Res; 2013 Oct; 1535():148-55. PubMed ID: 24012767
[TBL] [Abstract][Full Text] [Related]
17. Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
Sarami Foroshani M; Sobhani ZS; Mohammadi MT; Aryafar M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3053-3065. PubMed ID: 30093209
[TBL] [Abstract][Full Text] [Related]
18. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Shan Y; Tan S; Lin Y; Liao S; Zhang B; Chen X; Wang J; Deng Z; Zeng Q; Zhang L; Wang Y; Hu X; Qiu W; Peng L; Lu Z
J Neuroinflammation; 2019 Nov; 16(1):242. PubMed ID: 31779652
[TBL] [Abstract][Full Text] [Related]
19. Uric Acid Is Protective After Cerebral Ischemia/Reperfusion in Hyperglycemic Mice.
Justicia C; Salas-Perdomo A; Pérez-de-Puig I; Deddens LH; van Tilborg GAF; Castellví C; Dijkhuizen RM; Chamorro Á; Planas AM
Transl Stroke Res; 2017 Jun; 8(3):294-305. PubMed ID: 27981484
[TBL] [Abstract][Full Text] [Related]
20. An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke.
Zhang H; Liu Y; Guan S; Qu D; Wang L; Wang X; Li X; Zhou S; Zhou Y; Wang N; Meng J; Ma X
PLoS One; 2016; 11(2):e0148827. PubMed ID: 26863436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
